Hydroxypropyl-ß-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.

Mitrofanova, Alla; Molina, Judith; Varona Santos, Javier; Guzman, Johanna; Morales, Ximena A; Ducasa, G Michelle; Bryn, Jonathan; Sloan, Alexis; Volosenco, Ion; Kim, Jin-Ju; Ge, Mengyuan; Mallela, Shamroop K; Kretzler, Matthias; Eddy, Sean; Martini, Sebastian; Wahl, Patricia; Pastori, Santiago; Mendez, Armando J; Burke, George W; Merscher, Sandra; Fornoni, Alessia.
Kidney Int; 94(6): 1151-1159, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-30301568